Metaoxedrin Minims Bausch + Lomb Ireland Limited

Phenylephrine Hydrochloride, the active ingredient in Metaoxedrin Minims, is a sympathomimetic (alpha‑1 adrenergic agonist) presented as an ophthalmic solution for ocular use. It reduces conjunctival redness and can dilate the pupil to aid eye examinations. It is indicated for the temporary relief of ocular redness associated with minor irritations and is also employed by ophthalmologists to achieve pharmacologic mydriasis during diagnostic procedures.

GNH USA supplies Metaoxedrin Minims as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with established distribution networks across Europe, Asia and the Americas.

Phenylephrine Hydrochloride ophthalmic solution acts on the ocular vasculature by stimulating alpha‑1 adrenergic receptors, leading to vasoconstriction that relieves redness and produces pupil dilation, making it useful in several ophthalmic situations.

Ocular redness: reduces conjunctival hyperemia for temporary cosmetic relief. Conjunctival hyperemia: diminishes vessel engorgement to improve visual comfort. Mydriasis for eye examination: dilates the pupil to facilitate diagnostic procedures. Diagnostic pupil dilation: enables thorough retinal examination. Anterior segment imaging: provides adequate pupil size for photographic documentation.

Common Side Effects: - Transient burning or stinging sensation in the eye. - Mild ocular irritation or itching. - Temporary blurred vision after administration. - Mild headache.

Serious or Rare Side Effects: - Significant increase in intraocular pressure. - Allergic reactions such as eyelid swelling, rash, or angioedema. - Severe ocular pain or photophobia. - Systemic hypertension or cardiovascular events.

Phenylephrine ophthalmic solution should be used with caution in the following situations.

Contraindicated in narrow‑angle glaucoma: risk of further angle closure. Use with caution in cardiovascular disease: may raise blood pressure. Avoid concurrent use with other mydriatic agents: additive effect. Do not use if hypersensitivity to phenylephrine or any excipients: risk of allergic response. Store at room temperature: keep in original container, protect from light and moisture.

Phenylephrine ophthalmic solution may interact with other systemic or ocular agents.

Major Interactions (Avoid): - MAO inhibitors: may precipitate hypertensive crisis. - Systemic sympathomimetics (e.g., pseudoephedrine): additive vasoconstriction. - Tricyclic antidepressants: increased cardiovascular stimulation.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask tachycardia. - Antihypertensive therapy: phenylephrine may reduce efficacy. - Other ocular vasoconstrictors: additive ocular effects.